Health technology assessment : HTA
-
Health Technol Assess · Aug 2013
ReviewClinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation.
It is important that the level of general anaesthesia (GA) is appropriate for the individual patient undergoing surgery. If anaesthesia is deeper than required to keep a patient unconscious, there might be increased risk of anaesthetic-related morbidity, such as postoperative nausea, vomiting and cognitive dysfunction. This may also prolong recovery times, potentially increasing health-care costs. If anaesthesia is too light, patients may not be fully unconscious and could be at risk of intraoperative awareness. ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · Aug 2013
ReviewEchocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.
To investigate the clinical effectiveness and cost-effectiveness of transthoracic echocardiography (TTE) in all patients who are newly diagnosed with atrial fibrillation (AF). ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · Aug 2013
ReviewHome telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
Remote monitoring (RM) strategies have the potential to deliver specialised care and management to patients with heart failure (HF). ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · Aug 2013
ReviewCost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation.
Calcific aortic stenosis (AS) is a common valvular heart disease. Patients with severe symptomatic AS typically survive less than 3 years. In such patients, intervention with surgical aortic valve replacement (SAVR) may increase survival. However, in some patients SAVR is associated with a high operative risk and medical management is considered appropriate. Transcatheter aortic valve implantation (TAVI) is a relatively recent technique to avoid the invasiveness of open surgery. This procedure has been used for the treatment of patients with severe AS who are unsuitable for SAVR (because it is too high risk and/or for other reasons such as suffering from porcelain aorta) and is increasingly being considered for other patients. ⋯ The National Institute for Health Research Health Technology Assessment programme.